Scholarlink

<p>Postpartum depression (PPD) is a common, multifactorial condition impacting maternal and child health worldwide. Treatments include lifestyle, psychosocial, psychological (e.g. cognitive behavioural therapy) and pharmacological options such as selective serotonin reuptake inhibitors, with attention to breastfeeding considerations. Recent advances in neurobiology have led to the investigation of synthetic neuroactive steroids and their analogues (e.g. brexanolone, zuranolone) as potentially faster acting and more targeted treatments for PPD. Despite effective treatment options, barriers to care exist at the system, provider and patient levels. Emerging solutions include virtual care, task-sharing, culturally sensitive care and collaborative care models to improve access and outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Manage postpartum depression with evidence-based therapies while addressing barriers to care

  • 期刊论文

  • 发表日期：

    2025年9月11日

查看全文
  • Hannah A. Blair

摘要

Postpartum depression (PPD) is a common, multifactorial condition impacting maternal and child health worldwide. Treatments include lifestyle, psychosocial, psychological (e.g. cognitive behavioural therapy) and pharmacological options such as selective serotonin reuptake inhibitors, with attention to breastfeeding considerations. Recent advances in neurobiology have led to the investigation of synthetic neuroactive steroids and their analogues (e.g. brexanolone, zuranolone) as potentially faster acting and more targeted treatments for PPD. Despite effective treatment options, barriers to care exist at the system, provider and patient levels. Emerging solutions include virtual care, task-sharing, culturally sensitive care and collaborative care models to improve access and outcomes.